OBJECTIVE: According to the American Diabetes Association, the implementation of the standards of care for diabetes has been suboptimal in most clinical settings. Diabetes is a disease that had a total estimated cost of $174 billion in 2007 for an estimated diabetes-affected population of 17.5 million in the United States. With the advent of electronic medical records (EMR), tools to analyze data residing in the EMR for healthcare surveillance can help reduce the burdens experienced today. This study was primarily designed to evaluate the efficacy of employing clinical natural language processing to analyze discharge summaries for evidence indicating a presence of diabetes, as well as to assess diabetes protocol compliance and high risk factors. METHODS: Three sets of algorithms were developed to analyze discharge summaries for: (1) identification of diabetes, (2) protocol compliance, and (3) identification of high risk factors. The algorithms utilize a common natural language processing framework that extracts relevant discourse evidence from the medical text. Evidence utilized in one or more of the algorithms include assertion of the disease and associated findings in medical text, as well as numerical clinical measurements and prescribed medications. RESULTS: The diabetes classifier was successful at classifying reports for the presence and absence of diabetes. Evaluated against 444 discharge summaries, the classifier's performance included macro and micro F-scores of 0.9698 and 0.9865, respectively. Furthermore, the protocol compliance and high risk factor classifiers showed promising results, with most F-measures exceeding 0.9. CONCLUSIONS: The presented approach accurately identified diabetes in medical discharge summaries and showed promise with regards to assessment of protocol compliance and high risk factors. Utilizing free-text analytic techniques on medical text can complement clinical-public health decision support by identifying cases and high risk factors.
OBJECTIVE: According to the American Diabetes Association, the implementation of the standards of care for diabetes has been suboptimal in most clinical settings. Diabetes is a disease that had a total estimated cost of $174 billion in 2007 for an estimated diabetes-affected population of 17.5 million in the United States. With the advent of electronic medical records (EMR), tools to analyze data residing in the EMR for healthcare surveillance can help reduce the burdens experienced today. This study was primarily designed to evaluate the efficacy of employing clinical natural language processing to analyze discharge summaries for evidence indicating a presence of diabetes, as well as to assess diabetes protocol compliance and high risk factors. METHODS: Three sets of algorithms were developed to analyze discharge summaries for: (1) identification of diabetes, (2) protocol compliance, and (3) identification of high risk factors. The algorithms utilize a common natural language processing framework that extracts relevant discourse evidence from the medical text. Evidence utilized in one or more of the algorithms include assertion of the disease and associated findings in medical text, as well as numerical clinical measurements and prescribed medications. RESULTS: The diabetes classifier was successful at classifying reports for the presence and absence of diabetes. Evaluated against 444 discharge summaries, the classifier's performance included macro and micro F-scores of 0.9698 and 0.9865, respectively. Furthermore, the protocol compliance and high risk factor classifiers showed promising results, with most F-measures exceeding 0.9. CONCLUSIONS: The presented approach accurately identified diabetes in medical discharge summaries and showed promise with regards to assessment of protocol compliance and high risk factors. Utilizing free-text analytic techniques on medical text can complement clinical-public health decision support by identifying cases and high risk factors.
Authors: Anthony N Nguyen; Michael J Lawley; David P Hansen; Rayleen V Bowman; Belinda E Clarke; Edwina E Duhig; Shoni Colquist Journal: J Am Med Inform Assoc Date: 2010 Jul-Aug Impact factor: 4.497
Authors: Harvey J Murff; Fern FitzHenry; Michael E Matheny; Nancy Gentry; Kristen L Kotter; Kimberly Crimin; Robert S Dittus; Amy K Rosen; Peter L Elkin; Steven H Brown; Theodore Speroff Journal: JAMA Date: 2011-08-24 Impact factor: 56.272
Authors: Lois C Childs; Robert Enelow; Lone Simonsen; Norris H Heintzelman; Kimberly M Kowalski; Robert J Taylor Journal: J Am Med Inform Assoc Date: 2009-04-23 Impact factor: 4.497
Authors: Seyedmostafa Sheikhalishahi; Riccardo Miotto; Joel T Dudley; Alberto Lavelli; Fabio Rinaldi; Venet Osmani Journal: JMIR Med Inform Date: 2019-04-27
Authors: Susan E Spratt; Katherine Pereira; Bradi B Granger; Bryan C Batch; Matthew Phelan; Michael Pencina; Marie Lynn Miranda; Ebony Boulware; Joseph E Lucas; Charlotte L Nelson; Benjamin Neely; Benjamin A Goldstein; Pamela Barth; Rachel L Richesson; Isaretta L Riley; Leonor Corsino; Eugenia R McPeek Hinz; Shelley Rusincovitch; Jennifer Green; Anna Beth Barton; Carly Kelley; Kristen Hyland; Monica Tang; Amanda Elliott; Ewa Ruel; Alexander Clark; Melanie Mabrey; Kay Lyn Morrissey; Jyothi Rao; Beatrice Hong; Marjorie Pierre-Louis; Katherine Kelly; Nicole Jelesoff Journal: J Am Med Inform Assoc Date: 2017-04-01 Impact factor: 4.497